Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a special therapy help teens with fetal alcohol disorders?

NCT ID NCT06747650

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a therapy called dialectical behavior therapy (DBT) is helpful and acceptable for teens aged 14–17 with fetal alcohol spectrum disorders (FASD). Nine teens and their caregivers took part in a program that included individual therapy, group skills training, and phone coaching. The goal was to see if this approach could improve emotion regulation and reduce behavioral problems, and to learn how to run a larger study in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

9 people

The number who actually took part.

Started

Dec 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria: For adolescents: * Ages 14-17 years * Have a diagnosis of FASD under any diagnostic criteria * Residing in the state of New York * Willing and able to attend group sessions virtually * Have one of the following: 1. A diagnosis of disruptive mood dysregulation disorder, borderline personality disorder, or multiple other serious mental health diagnoses 2. A history of multiple psychiatric hospitalizations and/or recurring presentation at psychiatric emergency rooms 3. A score of 7+ on the McLean screening instrument (MSI; instrument attached and included in eligibility screen) * Have functional deficits in three of five problem areas: 1. Emotional dysregulation 2. Impulsivity (including avoidance) 3. Interpersonal challenges 4. Teenager and family challenges 5. Reduced awareness and focus * Access to the internet and device with Zoom capabilities For caregivers: * Parent or legal guardian of an adolescent (ages 14-17 years) with an FASD diagnosis * Residing in the state of New York * Willing and able to attend group sessions virtually * Access to the internet and device with Zoom capabilities For clinicians: * Employee of GVP * Administered DBT-A to teens with FASD as part of this study Exclusion Criteria: * • Adolescent, caregiver, or clinician has insufficient proficiency in English * Primary psychotic disorder * Ongoing substance/drug dependence or eating disorder at such a level that would impede engagement with DBT modalities (i.e. if an individual requires detoxification or hospitalization for stabilization) * Adolescent or caregiver has a moderate to severe intellectual disability (IQ \< 51)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal alcohol spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States